Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

517 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
SLMP53-2 Restores Wild-Type-Like Function to Mutant p53 through Hsp70: Promising Activity in Hepatocellular Carcinoma.
Gomes S, Bosco B, Loureiro JB, Ramos H, Raimundo L, Soares J, Nazareth N, Barcherini V, Domingues L, Oliveira C, Bisio A, Piazza S, Bauer MR, Brás JP, Almeida MI, Gomes C, Reis F, Fersht AR, Inga A, Santos MMM, Saraiva L. Gomes S, et al. Among authors: ramos h. Cancers (Basel). 2019 Aug 10;11(8):1151. doi: 10.3390/cancers11081151. Cancers (Basel). 2019. PMID: 31405179 Free PMC article.
Structural and Drug Targeting Insights on Mutant p53.
Gomes AS, Ramos H, Inga A, Sousa E, Saraiva L. Gomes AS, et al. Among authors: ramos h. Cancers (Basel). 2021 Jul 3;13(13):3344. doi: 10.3390/cancers13133344. Cancers (Basel). 2021. PMID: 34283062 Free PMC article. Review.
p53 family interactions and yeast: together in anticancer therapy.
Gomes S, Leão M, Raimundo L, Ramos H, Soares J, Saraiva L. Gomes S, et al. Among authors: ramos h. Drug Discov Today. 2016 Apr;21(4):616-24. doi: 10.1016/j.drudis.2016.02.007. Epub 2016 Feb 15. Drug Discov Today. 2016. PMID: 26891980 Review.
SLMP53-1 interacts with wild-type and mutant p53 DNA-binding domain and reactivates multiple hotspot mutations.
Gomes AS, Ramos H, Gomes S, Loureiro JB, Soares J, Barcherini V, Monti P, Fronza G, Oliveira C, Domingues L, Bastos M, Dourado DFAR, Carvalho AL, Romão MJ, Pinheiro B, Marcelo F, Carvalho A, Santos MMM, Saraiva L. Gomes AS, et al. Among authors: ramos h. Biochim Biophys Acta Gen Subj. 2020 Jan;1864(1):129440. doi: 10.1016/j.bbagen.2019.129440. Epub 2019 Sep 16. Biochim Biophys Acta Gen Subj. 2020. PMID: 31536751
BRCA1/P53: Two strengths in cancer chemoprevention.
Raimundo L, Ramos H, Loureiro JB, Calheiros J, Saraiva L. Raimundo L, et al. Among authors: ramos h. Biochim Biophys Acta Rev Cancer. 2020 Jan;1873(1):188339. doi: 10.1016/j.bbcan.2020.188339. Epub 2020 Jan 7. Biochim Biophys Acta Rev Cancer. 2020. PMID: 31917206 Review.
A selective p53 activator and anticancer agent to improve colorectal cancer therapy.
Ramos H, Soares MIL, Silva J, Raimundo L, Calheiros J, Gomes C, Reis F, Monteiro FA, Nunes C, Reis S, Bosco B, Piazza S, Domingues L, Chlapek P, Vlcek P, Fabian P, Rajado AT, Carvalho ATP, Veselska R, Inga A, Pinho E Melo TMVD, Saraiva L. Ramos H, et al. Cell Rep. 2021 Apr 13;35(2):108982. doi: 10.1016/j.celrep.2021.108982. Cell Rep. 2021. PMID: 33852837 Free article.
517 results